💪 Strong buy-in on revenue acceleration docs (90%+ agreement). Already mobilized Usaid to implement CRM changes. Proactive on near-term deal progression (UCB, Pfizer, Merck).
🎯 Shared Pfizer draft with champion before integrating Daniel's feedback - process gap. Pipeline reporting history shows past disconnect between board numbers and reality (acknowledged this is fixed now